This is from a report, MRI for the masses in July 2017 , new developments also open the door for new strategic partners like pharmaceutical or radiology companies? prior to this RHT had over 5,000 MRI centers world wide and 80 of the top Hospitals in the USA , Enter Siemens, RHT has bolted!
Resonance is working on its pipeline. With Resonance having developed technologies for use in additional organs including the bone marrow, pancreas and spleen, we see multiple growth horizons for Resonance beyond FerriScan and HepaFat-Scan. We see significant upside should Resonance succeed in creating an MRI-based diagnostic for liver inflammation or fibrosis. The new developments also open the door for new strategic partners like pharmaceutical or radiology companies. 9. Resonance has a leadership team with long experience with the technology.
https://www.resonancehealth.com/images/files/inverstors/RHT_report_ndf_research_20170717.pdf
Ann: Resonance Health Partners with Siemens healthineers, page-72
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.002(3.33%) |
Mkt cap ! $25.91M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.0¢ | 5.8¢ | $6.195K | 105.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 123488 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 116419 | 1 |
View Market Depth
| Last trade - 10.40am 03/10/2024 (20 minute delay) ? |
| RHT (ASX) Chart |